Projet SciLifeLab PULSE (Horizon Europe, appel à projets 2023)
Action : Cofund Postdoctoral programme
Statut du projet : SIGNED

SciLifeLab PULSE is a MSCA-COFUND postdoctoral programme of excellence in Life Sciences coordinated by the Swedish research infrastructure SciLifeLab. PULSE will recruit 48 postdocs in academic and entrepreneurial tracks, that will receive 3 years of international interdisciplinary and intersectoral career training focused on preparing them as impactful leaders in academia and/or industry. PULSE postdocs will be immersed in the internationally recognised scientific community of Universities (10), Research Institutes (4), Infrastructures (3), Companies (12) and Associations (4), providing joint core career and specialised training and access to cutting-edge high-technology infrastructures that comprise the foundation of SciLifeLab. At the heart of PULSE is a well-conceived core training programme, augmented by secondments to ensure necessary breadth and tailored individualised training adapted and relevant to academia and industry, and to facilitate international scientific exchange. The PULSE output will be a new breed of scientists, well-prepared in the application of high-throughput technologies and data-dense analytical approaches, and who can confidently meet the emerging societal challenges confronting the European Research Area, specifically in precision medicine, pandemic laboratory preparedness, planetary biology and drug discovery and development. PULSE is aligned with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers and takes into account the MSCA supervision guidelines and Green Charter. PULSE will have an impact that extends beyond its duration, establishing dialogues with multiple stakeholders in the non-academic sector and by setting new standards in postgraduate research training in Life Sciences internationally. PULSE will be administered by the Swedish Royal Institute of Technology (KTH), and has an overall budget of 19.0 MEUR, of which 36% stems from the EC and 64% from participating institutions.

Mots clés : postdoctoral training, career development, life sciences, open science, fair, data, technology, precision medicine, planetary biology, pandemic preparedness, drug discovery, drug development

Participants :
- KTH Institut royal de technologie (Suède) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 6877440.0 €
- Université de Turku (Finlande) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Lipum ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Vlaams Instituut voor Biotechnologie (Belgique) — Partner, associated partner, Recherche, subvention : 0.0 €
- Université de Malmö (Suède) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Coronavirus variants rapid response network (covarr-net) (Canada) — Partner, associated partner, Organismes publics (hors enseignement & recherche), subvention : 0.0 €
- Affibody (Sweden) (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Laboratoire européen de biologie moléculaire (Allemagne) — Partner, associated partner, Recherche, subvention : 0.0 €
- General Electric (Sweden) (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Beactica therapeutics ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Strike pharma ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Cytiva testa center ab (Suède) — Partner, associated partner, Autres, subvention : 0.0 €
- Université d'Uppsala (Suède) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Peptisystems ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Orion Corporation (Finland) (Finlande) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Prosilico (Suède) — Partner, associated partner, Recherche, subvention : 0.0 €
- Max Delbrück Center (Allemagne) — Partner, associated partner, Recherche, subvention : 0.0 €
- Bonsai biotherapeutics ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Akiram therapeutics ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Cyclic therapeutics ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Quretech bio ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Human Technopole (Italie) — Partner, associated partner, Recherche, subvention : 0.0 €
- European Infrastructure for Translational Medicine (Pays-Bas) — Partner, associated partner, Recherche, subvention : 0.0 €
- Research Institutes of Sweden (Suède) — Partner, associated partner, Organismes publics (hors enseignement & recherche), subvention : 0.0 €
- Université de Lund (Suède) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- AstraZeneca (Sweden) (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Red Glead Discovery (Sweden) (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Lakemedelsindustriforeningens service aktiebolag (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Swedenbio service ab (Suède) — Partner, associated partner, Autres, subvention : 0.0 €
- Ribocure pharmaceuticals ab (Suède) — Partner, associated partner, Recherche, subvention : 0.0 €